[{"address1": "7171 Frederick-Banting, Building 2", "address2": "Suite 270 St-Laurent", "city": "Montreal", "state": "QC", "zip": "H4S 1Z9", "country": "Canada", "phone": "857 412 7018", "website": "https://www.reparerx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Repare Therapeutics Inc., a clinical-stage precision oncology company, engages in the discovery and development of therapeutics in Switzerland and the United States. The company uses its proprietary, genome-wide and CRISPR-enabled SNIPRx platform to discover and develop cancer therapies that treat cancers due to mechanisms of genomic instability, including DNA damage repair. It also develops camonsertib (RP-3500), a potent and selective oral small molecule inhibitor of Ataxia-Telangiectasia and Rad3-related protein kinase that is in Phase 1/2 clinical trial for the treatment of solid tumors; and lunresertib (RP-6306), a selective and potent oral small molecule inhibitor of Protein Kinase Membrane-associated tyrosine-and threonine-specific cdc-2 inhibitory kinase that is in Phase 1/2 clinical trial. In addition, the company is developing RP-1664, an oral PLK4 inhibitor in Phase 1 clinical trial to harness the synthetic lethal relationship with TRIM37 amplification or overexpression in solid tumors; and RP-3467, an inhibitor of adenosinetriphosphatase activity on the helicase domain of DNA polymerase theta that is in Phase 1 clinical trial. The company has strategic collaborations with Hoffmann-La Roche Inc., F. HoffmannLa Roche Ltd, Debiopharm International S.A., Bristol-Myers Squibb Company, Ono Pharmaceutical Company Ltd., and New York University. Repare Therapeutics Inc. was incorporated in 2016 and is headquartered in Montreal, Canada.", "fullTimeEmployees": 129, "companyOfficers": [{"maxAge": 1, "name": "Dr. Michael  Zinda Ph.D.", "age": 53, "title": "Executive VP & Chief Scientific Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 661153, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steve  Forte CPA", "age": 45, "title": "President, CFO, CEO & Director", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 631996, "exercisedValue": 0, "unexercisedValue": 1765836}, {"maxAge": 1, "name": "Dr. Daniel  Durocher Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Frank  Sicheri Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Agnel  Sfeir Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sandra  Alves", "age": 45, "title": "Senior VP & Chief Accounting Officer", "yearBorn": 1979, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Belanger", "title": "Executive Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joseph P. O'Connell M.D.", "age": 70, "title": "Executive Vice President of Clinical Development and Medical Affairs", "yearBorn": 1954, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.69, "open": 1.68, "dayLow": 1.65, "dayHigh": 1.745, "regularMarketPreviousClose": 1.69, "regularMarketOpen": 1.68, "regularMarketDayLow": 1.65, "regularMarketDayHigh": 1.745, "payoutRatio": 0.0, "beta": 1.037, "forwardPE": -0.5690236, "volume": 151624, "regularMarketVolume": 151624, "averageVolume": 133101, "averageVolume10days": 181750, "averageDailyVolume10Day": 181750, "bid": 1.68, "ask": 2.12, "bidSize": 2, "askSize": 2, "marketCap": 72601000, "fiftyTwoWeekLow": 0.89, "fiftyTwoWeekHigh": 4.069, "allTimeHigh": 46.44, "allTimeLow": 0.89, "priceToSalesTrailing12Months": 290.404, "fiftyDayAverage": 1.7827, "twoHundredDayAverage": 1.44283, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -36222000, "profitMargins": 0.0, "floatShares": 22715092, "sharesOutstanding": 42959172, "sharesShort": 620829, "sharesShortPriorMonth": 644261, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.0145000005, "heldPercentInsiders": 0.01248, "heldPercentInstitutions": 0.64689004, "shortRatio": 5.15, "shortPercentOfFloat": 0.021300001, "impliedSharesOutstanding": 42959172, "bookValue": 2.57, "priceToBook": 0.6575876, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -109864000, "trailingEps": -2.58, "forwardEps": -2.97, "enterpriseToRevenue": -144.888, "enterpriseToEbitda": 0.328, "52WeekChange": -0.5432432, "SandP52WeekChange": 0.12121439, "quoteType": "EQUITY", "currentPrice": 1.69, "targetHighPrice": 3.0, "targetLowPrice": 3.0, "targetMeanPrice": 3.0, "targetMedianPrice": 3.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 109472000, "totalCashPerShare": 2.548, "ebitda": -110471000, "totalDebt": 649000, "quickRatio": 6.178, "currentRatio": 6.302, "totalRevenue": 250000, "debtToEquity": 0.588, "revenuePerShare": 0.006, "returnOnAssets": -0.38824, "returnOnEquity": -0.69958, "grossProfits": 15364000, "freeCashflow": -57422624, "operatingCashflow": -103338000, "revenueGrowth": -0.767, "grossMargins": 61.456, "ebitdaMargins": 0.0, "operatingMargins": -80.248, "financialCurrency": "USD", "symbol": "RPTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1592573400000, "postMarketChangePercent": 0.5917154, "postMarketPrice": 1.7, "postMarketChange": 0.00999999, "regularMarketChange": 0.0, "regularMarketDayRange": "1.65 - 1.745", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 133101, "fiftyTwoWeekLowChange": 0.8000001, "fiftyTwoWeekLowChangePercent": 0.8988765, "fiftyTwoWeekRange": "0.89 - 4.069", "fiftyTwoWeekHighChange": -2.3789997, "fiftyTwoWeekHighChangePercent": -0.5846645, "fiftyTwoWeekChangePercent": -54.32432, "earningsTimestampStart": 1762867800, "earningsTimestampEnd": 1762867800, "isEarningsDateEstimate": true, "exchange": "NMS", "messageBoardId": "finmb_435208167", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "Repare Therapeutics Inc.", "longName": "Repare Therapeutics Inc.", "corporateActions": [], "postMarketTime": 1762561335, "regularMarketTime": 1762549201, "regularMarketChangePercent": 0.0, "regularMarketPrice": 1.69, "marketState": "CLOSED", "epsTrailingTwelveMonths": -2.58, "epsForward": -2.97, "fiftyDayAverageChange": -0.092699885, "fiftyDayAverageChangePercent": -0.051999714, "twoHundredDayAverageChange": 0.24717009, "twoHundredDayAverageChangePercent": 0.17130923, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-06-19", "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "displayName": "Repare Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-11-08"}]